首頁 > 市場調查報告書 > 製藥

疫苗感染疾病

歐洲瘧疾治療市場預測至 2030 年 - 區域分析 - 按治療、給藥途徑和配銷通路

市場調查報告書

商品編碼

1510758

歐洲瘧疾治療市場預測至 2030 年 - 區域分析 - 按治療、給藥途徑和配銷通路

Europe Malaria Treatment Market Forecast to 2030 - Regional Analysis - by Treatment, Route of Administration, and Distribution Channel

出版日期: 2024年05月07日 | 出版商:

The Insight Partners | 英文 87 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2022年歐洲瘧疾治療市值為4.5169億美元，預計2030年將達到30.6097億美元；預計2022年至2030年複合年成長率為27.0%。

擴大新藥和疫苗研發線推動歐洲瘧疾治療市場

抗生素抗藥性會使大眾面臨許多疾病的風險，例如瘧疾。為了克服這個挑戰，新藥的研發被認為是最好的策略；因此，抗瘧藥物管道變得越來越強大。公私夥伴關係正在加速與瘧疾治療相關的研究活動。例如，非營利組織 Medicines for Malaria Venture (MMV) 與眾多製藥公司合作，透過開發新的治療方案來減輕瘧疾的負擔。

下表提到了一些正在臨床上開發的抗瘧藥：

表 1. 臨床開發中的瘧疾藥物/疫苗/化合物

藥物開發商臨床試驗階段

Artefenomel 賽諾菲 IIb 期

KAE609 諾華公司 IIb 期

KAF156 諾華公司 IIb 期

DSM265武田製藥公司IIa期

SANARIA PfSPZ-GA1 Sanaria 二期

SANARIA PfSPZ 疫苗 - 輻射減毒 PfSPZ 疫苗 Sanaria II 期

SANARIA PfSPZ-CVac Sanaria 二期

MSP3-CRM-Vac4All Vac4All 第一階段

肝期抗原 3 (LSA3) Vac4All IIa 期

資料來源：公司網站、Insight Partners 分析

因此，臨床開發中的抗瘧藥和藥物/疫苗數量的增加預計將推動未來市場的成長。

歐洲瘧疾治療市場概況

根據ECDC的監測報告，法國報告2020年瘧疾病例數最高。 2020年歐盟/歐洲經濟區國家報告的幾乎所有病例都是從其他國家前往法國的人中確診的；這些人主要包括與西非旅行路線有關的個人。在法國，惡性瘧原蟲幾乎是旅行者中所有嚴重病例和死亡的罪魁禍首。許多研究組織正在努力開發新方法來消除法國的瘧疾。例如，巴斯德研究所的團隊致力於瘧疾研究，旨在開發疫苗。這項研究對於尋找對抗瘧疾的新方法至關重要。巴斯德研究所還參加了一項名為 EVIMalaR 的歐洲重大項目，該項目涉及來自 7 個歐洲國家的 17 個研究機構和大學以及來自 3 個非洲國家的合作夥伴。這種消除瘧疾的合作努力正在推動法國瘧疾治療市場的成長。

歐洲瘧疾治療市場收入及 2030 年預測（百萬美元）

歐洲瘧疾治療市場細分

歐洲瘧疾治療市場根據治療、給藥途徑、配銷通路和國家進行細分。根據治療方法，歐洲瘧疾治療市場分為學名藥、原廠藥、疫苗等。 2022 年，學名藥細分市場佔最大市場佔有率。

就給藥途徑而言，歐洲瘧疾治療市場分為口服和腸外給藥。 2022年，口腔細分市場佔據了更大的市場。

依配銷通路，歐洲瘧疾治療市場分為直接招標、醫院藥局、零售藥局、線上藥局等。 2022 年，直接招標領域佔據最大的市場佔有率。

根據國家/地區，歐洲瘧疾治療市場分為英國、德國、法國、義大利、西班牙和歐洲其他地區。 2022 年，法國在歐洲瘧疾治療市場佔有率中佔據主導地位。

Cipla Ltd、Sun Pharmaceutical Industries Ltd、賽諾菲 SA、GSK Plc、諾華 AG、輝瑞 Inc 和 Lupin Ltd 是歐洲瘧疾治療市場的一些領先參與者。

Antimicrobial resistance can put the public at risk of many diseases, such as malaria. To overcome this challenge, the R&D of new medicines is considered the best strategy; as a result, the antimalarial pipeline is becoming increasingly robust. Public-private partnerships are accelerating research activities related to the treatment of malaria. For instance, Medicines for Malaria Venture (MMV), a nonprofit organization, works with numerous pharmaceutical companies to reduce the burden of malaria by developing novel treatment options.

A few antimalarial that are under clinical development are mentioned in the table below:

Table 1. Malaria Drugs/Vaccine/Compounds Under Clinical Development

Drug Developer Clinical Trial Stage

Artefenomel Sanofi Phase IIb

KAE609 Novartis AG Phase IIb

KAF156 Novartis AG Phase IIb

DSM265 Takeda Pharmaceutical Company Phase IIa

SANARIA PfSPZ-GA1 Sanaria Phase II

SANARIA PfSPZ Vaccine - Radiation Attenuated PfSPZ Vaccine Sanaria Phase II

SANARIA PfSPZ-CVac Sanaria Phase II

MSP3-CRM-Vac4All Vac4All Phase I

Liver-Stage Antigen-3 (LSA3) Vac4All Phase IIa

Source: Company Website, The Insight Partners Analysis

Therefore, the growing number of antimalarial and drugs/vaccines that are under clinical development are expected to boost the market growth in the future.

Europe Malaria Treatment Market Overview

According to a surveillance report by ECDC, France reported the highest number of malaria cases in 2020. In 2020, France reported 1,007 confirmed malaria cases. Nearly all the cases reported by EU/EEA countries in 2020 were diagnosed in people traveling to France from other countries; these mostly included individuals linked to travel routes from West Africa. In France, P. falciparum is responsible for almost all severe cases and deaths in travelers. Many research organizations are working toward developing new approaches to eliminate malaria in France. For example, teams at the Institut Pasteur are dedicated to malaria research aiming to develop vaccines. This research is vital in finding new ways of fighting malaria. The Institute Pasteur is also taking part in a major European program named EVIMalaR, which involves 17 research institutes and universities from 7 European countries, and partners from 3 African countries. Such collaborative efforts toward malaria elimination are driving the growth of the malaria treatment market in France.

Europe Malaria Treatment Market Revenue and Forecast to 2030 (US$ Million)

Europe Malaria Treatment Market Segmentation

The Europe malaria treatment market is segmented based on treatment, route of administration, distribution channel, and country. Based on treatment, the Europe malaria treatment market is segmented into generic drugs, originators, vaccines, and others. The generic drugs segment held the largest market share in 2022.

In terms of route of administration, the Europe malaria treatment market is bifurcated into oral and parenteral. The oral segment held a larger market share in 2022.

By distribution channel, the Europe malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment held the largest market share in 2022.

Based on country, the Europe malaria treatment market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. France dominated the Europe malaria treatment market share in 2022.

Cipla Ltd, Sun Pharmaceutical Industries Ltd, Sanofi SA, GSK Plc, Novartis AG, Pfizer Inc, and Lupin Ltd are some of the leading players operating in the Europe malaria treatment market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights - Malaria

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Malaria Treatment Market - Key Industry Dynamics

4.1 Key Market Drivers:
- 4.1.1 Increasing Prevalence of Malaria
4.2 Market Restraints
- 4.2.1 Availability of Counterfeit Antimalarial Drugs Followed by Subsequent Drug Resistance
4.3 Market Opportunities
- 4.3.1 Growing Strategic Initiatives by Market Players
4.4 Future Trends
- 4.4.1 Extending Pipeline of New Drugs and Vaccines
4.5 Impact Analysis

5. Malaria Treatment Market - Europe Market Analysis

5.1 Europe Malaria Treatment Market Revenue (US$ million), 2022 - 2030

6. Europe Malaria Treatment Market - Revenue and Forecast to 2030 - by Treatment

6.1 Overview
6.2 Europe Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
6.3 Vaccines
- 6.3.1 Overview
- 6.3.2 Vaccines Market Revenue and Forecast to 2030 (US$ Mn)
6.4 Generic Drugs
- 6.4.1 Overview
- 6.4.2 Generic Drugs Market Revenue and Forecast to 2030 (US$ Mn)
6.5 Originators
- 6.5.1 Overview
- 6.5.2 Originators Market Revenue and Forecast to 2030 (US$ Mn)
6.6 Others
- 6.6.1 Overview
- 6.6.2 Others Market Revenue and Forecast to 2030 (US$ Mn)

7. Europe Malaria Treatment Market - Revenue and Forecast to 2030 - by Route of Administration

7.1 Overview
7.2 Europe Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
7.3 Oral
- 7.3.1 Overview
- 7.3.2 Oral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Parenteral
- 7.4.1 Overview
- 7.4.2 Parenteral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Malaria Treatment Market - Revenue and Forecast to 2030 - by Distribution Channel

8.1 Overview
8.2 Europe Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
8.3 Direct Tender
- 8.3.1 Overview
- 8.3.2 Direct Tender: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Hospital Pharmacies
- 8.4.1 Overview
- 8.4.2 Hospital Pharmacies: Malaria Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Retail Pharmacies
- 8.5.1 Overview
- 8.5.2 Retail Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Online Pharmacies
- 8.6.1 Overview
- 8.6.2 Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Malaria Treatment Market - Country Analysis

9.1 Europe Malaria Treatment Market, Revenue and Forecast to 2030
- 9.1.1 Overview
  - 9.1.1.1 Europe: Malaria Treatment Market, by Countries
  - 9.1.1.2 France
  - 9.1.1.3 Overview
    - 9.1.1.3.1 France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.3.2 France: Malaria Treatment Market, by Treatment
    - 9.1.1.3.3 France: Malaria -Malaria Treatment Market, by Route of Administration
    - 9.1.1.3.4 France: Malaria Treatment Market, by Distribution Channel
    - 9.1.1.3.4.1 France: Malaria Treatment Market, by Hospital Pharmacies
    - 9.1.1.3.4.2 France: Malaria Treatment Market, by Retail Pharmacies
  - 9.1.1.4 UK
  - 9.1.1.5 Overview
    - 9.1.1.5.1 UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.5.2 UK: Malaria Treatment Market, by Treatment
    - 9.1.1.5.3 UK: Malaria -Malaria Treatment Market, by Route of Administration
    - 9.1.1.5.4 UK: Malaria Treatment Market, by Distribution Channel
    - 9.1.1.5.4.1 UK: Malaria Treatment Market, by Hospital Pharmacies
    - 9.1.1.5.4.2 UK: Malaria Treatment Market, by Retail Pharmacies
  - 9.1.1.6 Italy
  - 9.1.1.7 Overview
    - 9.1.1.7.1 Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.7.2 Italy: Malaria Treatment Market, by Treatment
    - 9.1.1.7.3 Italy: Malaria -Malaria Treatment Market, by Route of Administration
    - 9.1.1.7.4 Italy: Malaria Treatment Market, by Distribution Channel
    - 9.1.1.7.4.1 Italy: Malaria Treatment Market, by Hospital Pharmacies
    - 9.1.1.7.4.2 Italy: Malaria Treatment Market, by Retail Pharmacies
  - 9.1.1.8 Germany
  - 9.1.1.9 Overview
    - 9.1.1.9.1 Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.9.2 Germany: Malaria Treatment Market, by Treatment
    - 9.1.1.9.3 Germany: Malaria -Malaria Treatment Market, by Route of Administration
    - 9.1.1.9.4 Germany: Malaria Treatment Market, by Distribution Channel
    - 9.1.1.9.4.1 Germany: Malaria Treatment Market, by Hospital Pharmacies
    - 9.1.1.9.4.2 Germany: Malaria Treatment Market, by Retail Pharmacies
  - 9.1.1.10 Spain
  - 9.1.1.11 Overview
    - 9.1.1.11.1 Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.11.2 Spain: Malaria Treatment Market, by Treatment
    - 9.1.1.11.3 Spain: Malaria -Malaria Treatment Market, by Route of Administration
    - 9.1.1.11.4 Spain: Malaria Treatment Market, by Distribution Channel
    - 9.1.1.11.4.1 Spain: Malaria Treatment Market, by Hospital Pharmacies
    - 9.1.1.11.4.2 Spain: Malaria Treatment Market, by Retail Pharmacies
  - 9.1.1.12 Rest of Europe
  - 9.1.1.13 Overview
    - 9.1.1.13.1 Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.13.2 Rest of Europe: Malaria Treatment Market, by Treatment
    - 9.1.1.13.3 Rest of Europe: Malaria -Malaria Treatment Market, by Route of Administration
    - 9.1.1.13.4 Rest of Europe: Malaria Treatment Market, by Distribution Channel
    - 9.1.1.13.4.1 Rest of Europe: Malaria Treatment Market, by Hospital Pharmacies
    - 9.1.1.13.4.2 Rest of Europe: Malaria Treatment Market, by Retail Pharmacies

10. Malaria Treatment Market Industry Landscape

10.1 Overview
10.2 Growth Strategies in the Malaria Treatment Market
10.3 Inorganic Growth Strategies
- 10.3.1 Overview
10.4 Organic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 Cipla Ltd
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Sun Pharmaceutical Industries Ltd
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Sanofi SA
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 GSK Plc
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Novartis AG
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Pfizer Inc
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Service
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Lupin Ltd
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments

12. Appendix

12.1 About Us
12.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Malaria Treatment Market Segmentation
Table 2. Malaria Drugs/Vaccine/Compounds Under Clinical Development
Table 3. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 4. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 5. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 6. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 7. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 8. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 9. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 10. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 11. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 12. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 13. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 14. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 15. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 16. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 17. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 18. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 19. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 20. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 21. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 22. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 23. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 24. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 25. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 26. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 27. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 28. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 29. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 30. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 31. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 32. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 33. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 34. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 35. Recent Inorganic Growth Strategies in the Malaria Treatment Market
Table 36. Recent Organic Growth Strategies in the Malaria Treatment Market
Table 37. Glossary of Terms, Malaria Treatment Market

List Of Figures

Figure 1. Malaria Treatment Market - Key Industry Dynamics
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Europe Malaria Treatment Market Revenue (US$ million), 2022 - 2030
Figure 4. Europe Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
Figure 5. Vaccines Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 6. Generic Drugs Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 7. Originators Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 8. Others Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 9. Europe Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
Figure 10. Oral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Parenteral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Europe Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 13. Direct Tender: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Hospital Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Retail Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Europe Malaria Treatment Market, By Country, 2022 ($Mn)
Figure 19. Europe: Malaria Treatment Market, By Key Countries, 2022 and 2030 (%)
Figure 20. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 21. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 22. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. Growth Strategies in the Malaria Treatment Market